FDA Inspection 1236380 — Vivax Medical Corp.
The FDA completed an inspection of Vivax Medical Corp. on April 17, 2024 in Naugatuck, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Naugatuck, CT (United States)